VIETER
VIETNAM MARKET INTELLIGENCE

Cold Chain Logistics Market

Report Overview

The Global Cold Chain Logistics Market size is expected to be worth around USD 1633 Billion by 2035, from USD 393.3 Billion in 2025, growing at a CAGR of 15.3% during the forecast period from 2026 to 2035.

I define the Cold Chain Logistics market as an ecosystem enabling temperature-controlled storage and transportation. It supports perishables, pharmaceuticals, and specialty materials. Consequently, businesses rely on cold chain logistics to protect product integrity, ensure regulatory compliance, and reduce financial losses across supply chains.

Cold Chain Logistics Market Size

Together, these four players exemplify the blend of scale, technology, and strategic growth shaping the global cold chain logistics landscape in 2025.

Top Key Players in the Market

  • Lineage Logistics
  • Americold Logistics
  • NewCold Advanced Cold Logistics
  • Nichirei Logistics Group Inc.
  • Constellation Cold Logistics
  • United States Cold Storage, Inc
  • Frigolanda Cold Logistics Group
  • Emergent Cold Latin America
  • Snowman Logistics Ltd.
  • Conestoga Cold Storage
  • Interstate Cold Storage, Inc.
  • SuperFrio Logística Frigorificada
  • Vertical Cold Storage
  • Magnavale Ltd
  • Swire Cold Storage
  • Other Key Players

Recent Developments

  • In December 2025, Stonepeak announced the launch of Peregrine Cold Logistics, a dedicated cold chain logistics platform focused on Asia Pacific and the GCC, aimed at addressing the rapidly rising demand for temperature-controlled storage and distribution infrastructure across high-growth regions.
  • In January 2025, UPS successfully completed the acquisition of Frigo-Trans and BPL, strengthening its healthcare cold-chain capabilities in Europe by enhancing specialized logistics services for pharmaceuticals, biotech products, and complex medical supply chains.
  • In October 2025, Peli BioThermal announced a strategic acquisition to expand its cold chain logistics portfolio, with a strong focus on advancing cryogenic transport solutions for cell and gene therapies requiring ultra-low temperature control.